Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05828303
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2023-03-28
Brief Title:
A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin Digoxin and Rosuvastatin in Patients With Advanced Solid Tumors
Sponsor:
Turning Point Therapeutics Inc
Organization:
Turning Point Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-28
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-28
First Submit QC Date:
April 12 2023
Study First Post Date:
2023-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2024-04-11
Last Update Post Date Type:
ACTUAL